In terms of market side, this report researches the Influenza Vaccine revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

The global Influenza Vaccine market size in 2023 is 7209.2 million US dollars, and it is expected to be 12038.5 million US dollars by 2030, with a compound annual growth rate of 7.6% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Influenza Vaccine market include Sanofi S.A., AstraZeneca plc, CSL Limited, BIKEN Co, Ltd., and GlaxoSmithKline plc. The share of the top 3 players in the Influenza Vaccine market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Influenza Vaccine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Pediatrics accounted for XX% of Influenza Vaccine market in 2023. Adults share of XX%.
Injection accounted for XX% of the Influenza Vaccine market in 2023. Nasal Spray accounts for XX%.

Report Includes:
This report presents an overview of global market for Influenza Vaccine. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Influenza Vaccine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Influenza Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Influenza Vaccine market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Influenza Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Influenza Vaccine sales, projected growth trends, technology, application and end-user industry.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global Influenza Vaccine market by type, application and region. Analyze the revenue, sales and price of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Influenza Vaccine market region sales and revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of Influenza Vaccine market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players” M&A and New Entrants and Expansion Plans.
Chapter 11: Analyzes the main companies in the Influenza Vaccine industry, including their main businesses, products/services, sales, prices, revenue, gross margin, and the latest developments.
Chapter 12: Analyzes the Influenza Vaccine manufacturing cost, including raw material analysis, manufacturing cost structure, and industrial chain.
Chapter 13: Analyzes the Influenza Vaccine industry chain, including marketing channels, distributors and major downstream buyers.
Chapters 14-16: Provide detailed Influenza Vaccine market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 17: The main points and conclusions of the report.
Chapter 18: Concludes with an explanation of the data sources and research methods.

Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Sanofi S.A.
AstraZeneca plc
CSL Limited
BIKEN Co, Ltd.
GlaxoSmithKline plc
Abbott
Sinovac Biotech Ltd.
Viatris Inc.
Merck & Co, Inc.
EMERGEX VACCINES
Pfizer Inc.

Types list
Pediatrics
Adults

Application list
Injection
Nasal Spray

Table of Content

1 Influenza Vaccine Market Introduction and Overview
1.1 Influenza Vaccine Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Influenza Vaccine Industry Dynamic Analysis
1.5.1 Influenza Vaccine Market Trends Analysis
1.5.2 Influenza Vaccine Market Drivers Analysis
1.5.3 Influenza Vaccine Market Challenges Analysis
1.5.4 Influenza Vaccine Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Influenza Vaccine Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Influenza Vaccine Revenue and Share by Type
2.3 Global Influenza Vaccine Sales and Share by Type
3 Global Influenza Vaccine Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Influenza Vaccine Revenue and Share by Application (2019-2024)
3.3 Global Influenza Vaccine Sales and Share by Application (2019-2024)
4 Global Market Growth Insights
4.1 Global Influenza Vaccine Market Size (2019-2024)
4.2 Influenza Vaccine Growth Insights by Regions
4.2.1 Influenza Vaccine Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Influenza Vaccine Revenue Market Size by Regions (2019-2024)
4.2.3 Influenza Vaccine Sales Market Size by Regions (2019-2024)
4.2.4 North America Influenza Vaccine Market Size (2019-2024)
4.2.5 Europe Influenza Vaccine Market Size (2019-2024)
4.2.6 Asia-Pacific Influenza Vaccine Market Size (2019-2024)
4.2.7 Latin America Influenza Vaccine Market Size (2019-2024)
4.2.8 Middle East & Africa Influenza Vaccine Market Size (2019-2024)
5 North America
5.1 North America Influenza Vaccine Revenue by Countries
5.1.1 North America Influenza Vaccine Revenue by Countries (2019-2024)
5.1.2 North America Influenza Vaccine Sales by Countries (2019-2024)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Influenza Vaccine Revenue by Countries
6.1.1 Asia Pacific Influenza Vaccine Revenue by Countries (2019-2024)
6.1.2 Asia Pacific Influenza Vaccine Sales by Countries (2019-2024)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Influenza Vaccine Revenue by Countries
7.1.1 Europe Influenza Vaccine Revenue by Countries (2019-2024)
7.1.2 Europe Influenza Vaccine Sales by Countries (2019-2024)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Influenza Vaccine Revenue by Countries
8.1.1 Latin America Influenza Vaccine Revenue by Countries (2019-2024)
8.1.2 Latin America Influenza Vaccine Sales by Countries (2019-2024)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Influenza Vaccine Revenue by Countries
9.1.1 Middle East & Africa Influenza Vaccine Revenue by Countries (2019-2024)
9.1.2 Middle East & Africa Influenza Vaccine Sales by Countries (2019-2024)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Influenza Vaccine Market Competition, by Players
10.1 Global Influenza Vaccine Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Influenza Vaccine Players Market Share in 2023
10.2.2 Top 6 Influenza Vaccine Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Influenza Vaccine Players Head Office, Business Provided
10.4 Influenza Vaccine Mergers & Acquisitions
10.5 Influenza Vaccine New Entrants and Expansion Plans
11 Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Profile
11.1.2 Influenza Vaccine Product Overview
11.1.3 Sanofi S.A. Influenza Vaccine Market Performance (2019-2024)
11.1.4 Sanofi S.A. Business Overview
11.1.5 Recent Developments and Plans
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Profile
11.2.2 Influenza Vaccine Product Overview
11.2.3 AstraZeneca plc Influenza Vaccine Market Performance (2019-2024)
11.2.4 AstraZeneca plc Business Overview
11.2.5 Recent Developments and Plans
11.3 CSL Limited
11.3.1 CSL Limited Company Profile
11.3.2 Influenza Vaccine Product Overview
11.3.3 CSL Limited Influenza Vaccine Market Performance (2019-2024)
11.3.4 CSL Limited Business Overview
11.3.5 Recent Developments and Plans
11.4 BIKEN Co, Ltd.
11.4.1 BIKEN Co, Ltd. Company Profile
11.4.2 Influenza Vaccine Product Overview
11.4.3 BIKEN Co, Ltd. Influenza Vaccine Market Performance (2019-2024)
11.4.4 BIKEN Co, Ltd. Business Overview
11.4.5 Recent Developments and Plans
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Profile
11.5.2 Influenza Vaccine Product Overview
11.5.3 GlaxoSmithKline plc Influenza Vaccine Market Performance (2019-2024)
11.5.4 GlaxoSmithKline plc Business Overview
11.5.5 Recent Developments and Plans
11.6 Abbott
11.6.1 Abbott Company Profile
11.6.2 Influenza Vaccine Product Overview
11.6.3 Abbott Influenza Vaccine Market Performance (2019-2024)
11.6.4 Abbott Business Overview
11.6.5 Recent Developments and Plans
11.7 Sinovac Biotech Ltd.
11.7.1 Sinovac Biotech Ltd. Company Profile
11.7.2 Influenza Vaccine Product Overview
11.7.3 Sinovac Biotech Ltd. Influenza Vaccine Market Performance (2019-2024)
11.7.4 Sinovac Biotech Ltd. Business Overview
11.7.5 Recent Developments and Plans
11.8 Viatris Inc.
11.8.1 Viatris Inc. Company Profile
11.8.2 Influenza Vaccine Product Overview
11.8.3 Viatris Inc. Influenza Vaccine Market Performance (2019-2024)
11.8.4 Viatris Inc. Business Overview
11.8.5 Recent Developments and Plans
11.9 Merck & Co, Inc.
11.9.1 Merck & Co, Inc. Company Profile
11.9.2 Influenza Vaccine Product Overview
11.9.3 Merck & Co, Inc. Influenza Vaccine Market Performance (2019-2024)
11.9.4 Merck & Co, Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 EMERGEX VACCINES
11.10.1 EMERGEX VACCINES Company Profile
11.10.2 Influenza Vaccine Product Overview
11.10.3 EMERGEX VACCINES Influenza Vaccine Market Performance (2019-2024)
11.10.4 EMERGEX VACCINES Business Overview
11.10.5 Recent Developments and Plans
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Profile
11.11.2 Influenza Vaccine Product Overview
11.11.3 Pfizer Inc. Influenza Vaccine Market Performance (2019-2024)
11.11.4 Pfizer Inc. Business Overview
11.11.5 Recent Developments and Plans
12 Influenza Vaccine Manufacturing Cost Analysis
12.1 Influenza Vaccine Key Raw Materials Analysis
12.1.1 Key Raw Materials
12.1.2 Price Trend of Key Raw Materials
12.1.3 Key Suppliers of Raw Materials
12.2 Proportion of Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Manufacturing Process Analysis of Influenza Vaccine
12.4 Influenza Vaccine Industrial Chain Analysis
13 Market Channel, Distributors, Traders and Dealers
13.1 Market Channel Status
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Influenza Vaccine Typical Distributors
13.3 Influenza Vaccine Typical Customers
14 Global Influenza Vaccine Forecast Market Insights by Type
14.1 Global Influenza Vaccine Revenue Market Forecast by Type (2024-2030)
14.2 Global Influenza Vaccine Sales Market Forecast by Type (2024-2030)
15 Global Influenza Vaccine Forecast Market Insights by Application
15.1 Influenza Vaccine Revenue Market Forecast by Application (2024-2030)
15.2 Influenza Vaccine Sales Market Forecast by Application (2024-2030)
16 Global Market Growth Forecast Insights
16.1 Global Influenza Vaccine Forecast Market Size (2024-2030)
16.2 Influenza Vaccine Growth Forecast Insights by Regions
16.2.1 Influenza Vaccine Revenue Forecast Market Size by Regions (2024-2030)
16.2.2 Influenza Vaccine Sales Forecast Market Size by Regions (2024-2030)
16.2.3 North America Influenza Vaccine Forecast Market Size (2024-2030)
16.2.4 Europe Influenza Vaccine Forecast Market Size (2024-2030)
16.2.5 Asia-Pacific Influenza Vaccine Forecast Market Size (2024-2030)
16.2.6 Latin America Influenza Vaccine Forecast Market Size (2024-2030)
16.2.7 Middle East & Africa Influenza Vaccine Forecast Market Size (2024-2030)
17 Research Findings and Conclusion
18 Methodology and Data Source
18.1 A Methodology
18.1.1 Research Process
18.1.2 Market Size Estimation
18.1.3 Market Breakdown and Data Triangulation
18.2 B Data Source
18.2.1 Legal Disclaimer

List of Tables and Figures

Figure Influenza Vaccine Picture
Table Product Definition of Influenza Vaccine
Table Global Influenza Vaccine Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
Table Global Influenza Vaccine Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
Figure Years Considered
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Influenza Vaccine Production by Players (2019-2024)
Table Global Influenza Vaccine Production Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Influenza Vaccine in 2024
Figure Top 10 Largest Players of Influenza Vaccine in 2024
Table Global Influenza Vaccine Revenue by Players (2019-2024)
Table Global Influenza Vaccine Revenue Market Share by Players (2019-2024)
Figure Top 5 Largest Players of Influenza Vaccine in 2024
Figure Top 10 Largest Players of Influenza Vaccine in 2024
Table Global Influenza Vaccine Production Price by Players
Table Players Market Concentration Ratio (CR5)
Table Global Influenza Vaccine Players Geographical Distribution
Table Mergers & Acquisitions, Expansion Plans
Table Company Profiles
Table Sanofi S.A. Overview
Table Sanofi S.A. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Sanofi S.A. Related Developments
Table Company Profiles
Table AstraZeneca plc Overview
Table AstraZeneca plc Production, Price, Value, Gross, Gross Margin 2019-2024
Table AstraZeneca plc Related Developments
Table Company Profiles
Table CSL Limited Overview
Table CSL Limited Production, Price, Value, Gross, Gross Margin 2019-2024
Table CSL Limited Related Developments
Table Company Profiles
Table BIKEN Co, Ltd. Overview
Table BIKEN Co, Ltd. Production, Price, Value, Gross, Gross Margin 2019-2024
Table BIKEN Co, Ltd. Related Developments
Table Company Profiles
Table GlaxoSmithKline plc Overview
Table GlaxoSmithKline plc Production, Price, Value, Gross, Gross Margin 2019-2024
Table GlaxoSmithKline plc Related Developments
Table Company Profiles
Table Abbott Overview
Table Abbott Production, Price, Value, Gross, Gross Margin 2019-2024
Table Abbott Related Developments
Table Company Profiles
Table Sinovac Biotech Ltd. Overview
Table Sinovac Biotech Ltd. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Sinovac Biotech Ltd. Related Developments
Table Company Profiles
Table Viatris Inc. Overview
Table Viatris Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Viatris Inc. Related Developments
Table Company Profiles
Table Merck & Co, Inc. Overview
Table Merck & Co, Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Merck & Co, Inc. Related Developments
Table Company Profiles
Table EMERGEX VACCINES Overview
Table EMERGEX VACCINES Production, Price, Value, Gross, Gross Margin 2019-2024
Table EMERGEX VACCINES Related Developments
Table Company Profiles
Table Pfizer Inc. Overview
Table Pfizer Inc. Production, Price, Value, Gross, Gross Margin 2019-2024
Table Pfizer Inc. Related Developments
Table Global Influenza Vaccine Production by Type (2019-2024)
Table Global Influenza Vaccine Production Share by Type (2019-2024)
Table Global Influenza Vaccine Forecasted Production by Type (2024-2030)
Table Global Influenza Vaccine Forecasted Production Share by Type (2024-2030)
Table Global Influenza Vaccine Value by Type (2019-2024)
Table Global Influenza Vaccine Value Share by Type (2019-2024)
Table Global Influenza Vaccine Forecasted Value by Type (2024-2030)
Table Global Influenza Vaccine Forecasted Value Share by Type (2024-2030)
Table Global Influenza Vaccine Price by Type (2019-2024)
Table Global Influenza Vaccine Price Forecast by Type (2024-2030)
Table Global Influenza Vaccine Consumption by Application (2019-2024)
Table Global Influenza Vaccine Consumption Share by Application (2019-2024)
Table Global Influenza Vaccine Forecasted Consumption by Application (2024-2030)
Table Global Influenza Vaccine Forecasted Consumption Share by Application (2024-2030)
Table Global Influenza Vaccine Revenue by Application (2019-2024)
Table Global Influenza Vaccine Revenue Share by Application (2019-2024)
Table Global Influenza Vaccine Forecasted Revenue by Application (2024-2030)
Table Global Influenza Vaccine Forecasted Revenue Share by Application (2024-2030)
Table Global Influenza Vaccine Price by Application (2019-2024)
Table Global Influenza Vaccine Price Forecast by Application (2024-2030)
Figure Global Influenza Vaccine Production (2019-2030)
Figure Global Influenza Vaccine Value (2019-2030)
Table Global Influenza Vaccine Production by Region: 2019 VS 2024 VS 2030
Table Global Influenza Vaccine Historic Production by Region (2019-2024)
Table Global Influenza Vaccine Historic Production Share by Region (2019-2024)
Table Global Influenza Vaccine Historic Value by Region (2019-2024)
Table Global Influenza Vaccine Historic Value Share by Region (2019-2024)
Table Global Influenza Vaccine Forecasted Production by Region (2024-2030)
Table Global Influenza Vaccine Forecasted Production Share by Region (2024-2030)
Table Global Influenza Vaccine Forecasted Value by Region (2024-2030)
Table Global Influenza Vaccine Forecasted Value Share by Region (2024-2030)
Figure North America Influenza Vaccine Production (2019-2030)
Figure North America Influenza Vaccine Value (2019-2030)
Table North America Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Europe Influenza Vaccine Production (2019-2030)
Figure Europe Influenza Vaccine Value (2019-2030)
Table Europe Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure China Influenza Vaccine Production (2019-2030)
Figure China Influenza Vaccine Value (2019-2030)
Table China Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Japan Influenza Vaccine Production (2019-2030)
Figure Japan Influenza Vaccine Value (2019-2030)
Table Japan Production, Price, Value, Gross, Gross Margin 2019-2024
Table SWOT Analysis
Figure Global Influenza Vaccine Sales Estimates and Forecasts 2019-2030
Table Global Influenza Vaccine Sales by Region: 2019 VS 2024 VS 2030
Table Global Influenza Vaccine Sales by Region (2019-2024)
Table Global Influenza Vaccine Sales Share by Region (2019-2024)
Table Global Influenza Vaccine Sales by Region (2024-2030)
Table Global Influenza Vaccine Sales Share by Region (2024-2030)
Figure North America Influenza Vaccine Sales (2019-2030)
Table North America Influenza Vaccine Sales by Country (2019-2030)
Table North America Influenza Vaccine Sales Share by Country (2019-2030)
Figure United States Influenza Vaccine Sales Market Size (2019-2030)
Figure Canada Influenza Vaccine Sales Market Size (2019-2030)
Figure Europe Influenza Vaccine Sales (2019-2030)
Table Europe Influenza Vaccine Sales by Country (2019-2030)
Table Europe Influenza Vaccine Sales Share by Country (2019-2030)
Figure Germany Influenza Vaccine Sales Market Size (2019-2030)
Figure France Influenza Vaccine Sales Market Size (2019-2030)
Figure U.K. Influenza Vaccine Sales Market Size (2019-2030)
Figure Italy Influenza Vaccine Sales Market Size (2019-2030)
Figure Russia Influenza Vaccine Sales Market Size (2019-2030)
Figure Asia-Pacific Influenza Vaccine Sales (2019-2030)
Table Asia Pacific Influenza Vaccine Sales by Region (2019-2030)
Table Asia Pacific Influenza Vaccine Sales Share by Region (2019-2030)
Figure China Influenza Vaccine Sales Market Size (2019-2030)
Figure Japan Influenza Vaccine Sales Market Size (2019-2030)
Figure South Korea Influenza Vaccine Sales Market Size (2019-2030)
Figure India Influenza Vaccine Sales Market Size (2019-2030)
Figure Southeast Asia Influenza Vaccine Sales Market Size (2019-2030)
Figure Australia Influenza Vaccine Sales Market Size (2019-2030)
Figure Latin America Influenza Vaccine Sales (2019-2030)
Table Latin America Influenza Vaccine Sales by Country (2019-2030)
Table Latin America Influenza Vaccine Sales Share by Country (2019-2030)
Figure Mexico Influenza Vaccine Sales Market Size (2019-2030)
Figure Brazil Influenza Vaccine Sales Market Size (2019-2030)
Figure Middle East & Africa Influenza Vaccine Sales (2019-2030)
Table Middle East and Africa Influenza Vaccine Sales by Country (2019-2030)
Table Middle East and Africa Influenza Vaccine Sales Share by Country (2019-2030)
Figure Turkey Influenza Vaccine Sales Market Size (2019-2030)
Figure Saudi Arabia Influenza Vaccine Sales Market Size (2019-2030)
Figure U.A.E Influenza Vaccine Sales Market Size (2019-2030)
Table Raw Material
Table Raw Materials Key Suppliers
Figure Sales Channels
Table Major Distributors of Influenza Vaccine with Contact Information
Table Major Customers of Influenza Vaccine with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report